The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Alectinib

Australian Public Assessment Report

AusPAR

AusPAR: Alectinib [PDF, 633.89 KB]

AusPAR: Alectinib [Word, 1.51 MB]

Attachment: Product Information: Alectinib [PDF, 349.32 KB]

Attachment: Product Information: Alectinib [Word, 312.89 KB]

Attachment: Extract from Clinical Evaluation Alectinib [PDF, 4.12 MB]

Attachment: Extract from Clinical Evaluation Alectinib [Word, 18.21 MB]

Device/Product Name

Alecensa

Active ingredients

Alectinib

AusPAR Date

5 March 2018

Published

26 March 2018

Submission Number

PM-2017-03224-1-4

Submission Type

Extension of indications

Decision

Approved